TITA

COM:TITANBIOTECHLTD

Titan Biotech Ltd.

  • Stock

Last Close

893.60

08/11 10:12

Market Cap

4.96B

Beta: -

Volume Today

8.30K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
average inventory
61.49M
-
89.70M
45.87%
110.28M
22.95%
127.43M
15.55%
160.41M
25.88%
193.58M
20.68%
245.54M
26.84%
302.57M
23.22%
374.16M
23.66%
392.32M
4.85%
average payables
14.71M
-
14.37M
2.29%
15.63M
8.73%
15.55M
0.52%
12.45M
19.92%
16.16M
29.83%
31.34M
93.95%
39.19M
25.02%
56.31M
43.69%
65.49M
16.30%
average receivables
46.40M
-
70.35M
51.61%
78.89M
12.15%
78.89M
0.01%
77.81M
1.37%
85.09M
9.35%
105.53M
24.02%
149.83M
41.98%
172.31M
15.01%
186.83M
8.43%
book value per share
21.79
-
26.46
21.39%
27.82
5.16%
29.74
6.89%
31.47
5.85%
38.94
23.71%
47.43
21.81%
83.21
75.43%
119.40
43.50%
133.00
11.39%
capex per share
-2.30
-
-2.17
5.52%
-5.96
174.09%
-9.26
55.39%
-7.44
19.71%
-5.38
27.63%
-6.60
22.58%
-5.89
10.76%
-22.73
286.13%
-24.76
8.91%
capex to depreciation
-1.98
-
-2.01
1.53%
-5.99
198.20%
-8.79
46.80%
-6.18
29.72%
-2.60
57.92%
-3.03
16.54%
-2.19
27.55%
-7.40
237.29%
-7.87
6.32%
capex to operating cash flow
3.67
-
0.93
74.54%
-0.96
202.90%
-54.02
5,514.73%
-3.04
94.38%
-0.81
73.20%
-0.89
9.56%
-0.25
71.40%
-0.82
222.33%
-0.97
17.56%
capex to revenue
-0.04
-
-0.04
0.83%
-0.10
141.42%
-0.14
34.98%
-0.10
26.26%
-0.07
31.69%
-0.07
0.16%
-0.03
50.16%
-0.12
259.42%
-0.14
15.58%
cash per share
2.79
-
0.47
83.34%
4.61
889.82%
5.55
20.60%
1.60
71.12%
2.46
53.62%
2.25
8.78%
6.82
203.37%
14.39
111.08%
7.52
47.74%
days of inventory on hand
82.88
-
134.26
61.98%
118.14
12.01%
131.71
11.49%
166.86
26.68%
191.06
14.51%
214.35
12.19%
157.75
26.40%
206.17
30.69%
188.94
8.36%
days payables outstanding
17.56
-
17.21
2.02%
18.35
6.65%
12.74
30.59%
10.32
19.00%
19.39
87.94%
31.60
62.94%
18.00
43.02%
36.79
104.36%
28.99
21.21%
days sales outstanding
58.58
-
70.51
20.37%
63.72
9.63%
53.94
15.34%
49.46
8.31%
51.98
5.09%
54.51
4.86%
46.46
14.77%
39.08
15.89%
53.25
36.27%
debt to assets
0.25
-
0.23
8.12%
0.28
23.77%
0.43
51.08%
0.45
5.43%
0.37
19.47%
0.31
14.06%
0.15
53.23%
0.14
2.19%
0.06
55.94%
debt to equity
0.46
-
0.38
17.32%
0.53
40.71%
0.98
84.14%
1.06
8.44%
0.74
30.54%
0.61
17.12%
0.22
64.69%
0.21
2.96%
0.08
62.90%
dividend yield
0.00
-
0.00
2.87%
0.00
0%
0.00
0%
0.00
0%
0.00
-
0.00
50.01%
0.00
0%
earnings yield
0.01
-
0.01
0.50%
0.01
8.35%
0.01
23.34%
0.01
16.61%
0.01
29.71%
0.02
100.60%
0.09
329.33%
0.08
15.86%
0.08
2.66%
enterprise value
2.86B
-
3.16B
10.59%
3.18B
0.49%
3.27B
2.95%
3.34B
2.07%
3.51B
5.30%
3.52B
0.08%
3.39B
3.61%
3.35B
1.28%
3.33B
0.40%
enterprise value over ebitda
83.99
-
76.05
9.46%
76.39
0.45%
59.00
22.77%
45.93
22.16%
36.52
20.49%
25.70
29.63%
7.19
72.01%
7.97
10.73%
10.60
33.02%
ev to operating cash flow
-647.94
-
-175.61
72.90%
66.26
137.73%
2.46K
3,619.88%
176.08
92.86%
64.30
63.49%
57.51
10.55%
17.77
69.10%
14.64
17.59%
15.74
7.50%
ev to sales
7.30
-
7.84
7.34%
6.94
11.48%
6.21
10.58%
5.82
6.26%
5.42
6.92%
4.43
18.23%
2.38
46.17%
2.19
8.11%
2.32
5.69%
free cash flow per share
-2.93
-
-4.50
53.69%
0.23
105.22%
-9.09
3,971.60%
-4.99
45.14%
1.23
124.73%
0.80
34.80%
17.20
2,039.17%
4.93
71.34%
0.87
82.36%
free cash flow yield
-0.01
-
-0.01
53.69%
0.00
105.22%
-0.02
3,971.60%
-0.01
45.14%
0.00
124.73%
0.00
34.80%
0.04
2,039.17%
0.01
71.34%
0.00
82.36%
graham net net
-3.48
-
-1.68
51.78%
-3.04
81.17%
-13.77
353.58%
-19.90
44.50%
-13.84
30.46%
-11.80
14.73%
8.76
174.25%
8.86
1.13%
18.70
110.99%
graham number
32.24
-
35.43
9.90%
37.82
6.74%
43.42
14.82%
48.24
11.10%
61.11
26.68%
95.52
56.32%
262.15
174.44%
288.05
9.88%
299.95
4.13%
income quality
-0.20
-
-0.73
272.00%
1.81
346.14%
0.04
97.81%
0.46
1,066.95%
0.99
113.24%
0.59
40.38%
0.45
23.99%
0.60
33.93%
0.75
25.87%
intangibles to total assets
0
-
0
0
0.00
Infinity%
0.00
25.59%
0.00
55.57%
0.00
8.78%
0.00
31.39%
0.00
19.96%
0.00
13.12%
interest coverage
10.96
-
3.87
64.69%
4.25
9.84%
3.47
18.47%
2.71
21.97%
3.32
22.91%
5.67
70.44%
29.63
422.95%
22.80
23.06%
36.77
61.26%
interest debt per share
10.26
-
11.07
7.89%
15.68
41.64%
30.72
95.88%
36.19
17.82%
31.24
13.67%
31.39
0.46%
19.69
37.28%
26.47
34.48%
11.20
57.68%
inventory turnover
4.40
-
2.72
38.27%
3.09
13.64%
2.77
10.31%
2.19
21.06%
1.91
12.67%
1.70
10.87%
2.31
35.88%
1.77
23.49%
1.93
9.12%
invested capital
0.46
-
0.38
17.32%
0.53
40.71%
0.98
84.14%
1.06
8.44%
0.74
30.54%
0.61
17.12%
0.22
64.69%
0.21
2.96%
0.08
62.90%
market cap
2.81B
-
3.09B
9.95%
3.09B
0%
3.09B
0%
3.09B
0%
3.30B
6.78%
3.30B
0%
3.30B
0%
3.30B
0%
3.30B
0%
net current asset value
39.57M
-
82.27M
107.92%
63.83M
22.42%
14.92M
76.63%
-19.92M
233.55%
41.63M
308.97%
97.03M
133.08%
305.87M
215.22%
533.61M
74.46%
437.01M
18.10%
net debt to ebitda
1.48
-
1.77
19.87%
2.14
21.20%
3.30
53.83%
3.44
4.49%
2.26
34.33%
1.61
28.82%
0.20
87.70%
0.12
40.09%
0.12
2.32%
net income per share
2.12
-
2.11
0.50%
2.28
8.35%
2.82
23.34%
3.29
16.61%
4.26
29.71%
8.55
100.60%
36.71
329.33%
30.89
15.86%
30.06
2.66%
operating cash flow per share
-0.63
-
-2.33
271.11%
6.20
366.36%
0.17
97.23%
2.45
1,328.65%
6.62
170.05%
7.40
11.88%
23.09
211.98%
27.66
19.79%
25.63
7.35%
payables turnover
20.79
-
21.21
2.06%
19.89
6.24%
28.65
44.06%
35.38
23.46%
18.82
46.79%
11.55
38.63%
20.27
75.49%
9.92
51.07%
12.59
26.92%
receivables turnover
6.23
-
5.18
16.92%
5.73
10.66%
6.77
18.12%
7.38
9.07%
7.02
4.84%
6.70
4.64%
7.86
17.32%
9.34
18.89%
6.85
26.62%
research and ddevelopement to revenue
0.00
-
0.00
0.95%
0.00
204.29%
0.00
66.55%
0.00
8.72%
0.00
50.50%
0.00
130.29%
0.00
1.61%
return on tangible assets
0.05
-
0.05
8.91%
0.04
9.37%
0.04
4.91%
0.04
6.98%
0.05
21.35%
0.09
70.74%
0.30
224.00%
0.18
40.92%
0.18
3.76%
revenue per share
55.60
-
52.10
6.30%
59.14
13.53%
68.09
15.12%
74.14
8.89%
78.55
5.94%
96.13
22.39%
172.12
79.05%
184.92
7.43%
174.26
5.77%
roe
0.10
-
0.08
18.04%
0.08
3.04%
0.09
15.39%
0.10
10.16%
0.11
4.85%
0.18
64.69%
0.44
144.72%
0.26
41.37%
0.23
12.62%
roic
0.08
-
0.08
1.47%
0.06
20.21%
0.07
4.48%
0.08
19.98%
0.09
16.23%
0.14
53.05%
0.38
173.80%
0.18
52.77%
0.17
5.24%
sales general and administrative to revenue
0.09
-
0.00
96.37%
0.00
21.38%
0.01
489.93%
0.01
2.53%
0.02
22.92%
0.01
24.66%
0.01
23.56%
0.01
38.92%
shareholders equity per share
21.79
-
26.46
21.39%
27.82
5.16%
29.74
6.89%
31.47
5.85%
38.94
23.71%
47.43
21.81%
83.21
75.43%
119.40
43.50%
133.00
11.39%
stock based compensation to revenue
tangible asset value
153.40M
-
204.73M
33.46%
226.54M
10.65%
239.06M
5.53%
253.62M
6.09%
336.64M
32.73%
414.44M
23.11%
723.84M
74.66%
1.05B
45.48%
1.10B
4.29%
tangible book value per share
21.79
-
26.46
21.39%
29.27
10.65%
30.89
5.53%
32.77
6.09%
40.74
24.30%
50.15
23.11%
87.59
74.66%
127.43
45.48%
132.90
4.29%
working capital
81.35M
-
107.85M
32.57%
111.19M
3.10%
172.86M
55.46%
182.60M
5.64%
193.58M
6.01%
237.68M
22.78%
395.47M
66.39%
661.19M
67.19%
479.55M
27.47%

All numbers in (except ratios and percentages)